Effect of Shifting from Combination Therapy to Monotherapy of α-Blockers or 5α-Reductase Inhibitors on Prostate Volume and Symptoms in Patients with Benign Prostatic Hyperplasia

Effect of Shifting from Combination Therapy to Monotherapy of α-Blockers or 5α-Reductase Inhibitors on Prostate Volume and Symptoms in Patients with Benign Prostatic Hyperplasia

Bibliographic Details
Main Authors:	Kim, Hyoung Woo, Moon, Dae Geun, Kim, Hyun Min, Hwang, Jong Ho, Kim, Soon Chan, Nam, Sam Geuk, Park, Jun Tag
Format:	Online
Language:	English
Published:	The Korean Urological Association 2011
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3212662/

Similar Items

α-Blocker Monotherapy and α-Blocker Plus 5-Alpha-Reductase Inhibitor Combination Treatment in Benign Prostatic Hyperplasia; 10 Years' Long-Term Results
by: Shin, Teak Jun, et al.
Published: (2012)

Medical therapy for clinical benign prostatic hyperplasia: α1 Antagonists, 5α reductase inhibitors and their combination
by: Cheuk Fan Shum, et al.
Published: (2017-07-01)

Cinnamomi Cortex (Cinnamomum verum) Suppresses Testosterone-induced Benign Prostatic Hyperplasia by Regulating 5α-reductase
by: Choi, Hyun-Myung, et al.
Published: (2016)

Benign Prostatic Hyperplasia: from Bench to Clinic
by: Yoo, Tag Keun, et al.
Published: (2012)

Ramelteon combined with an α1-blocker decreases nocturia in men with benign prostatic hyperplasia
by: Kawahara, Takashi, et al.
Published: (2013)

Personalized therapeutics of α1-blockers in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia
by: Zhu, Ling-ling, et al.
Published: (2015)

A Dual 5α-Reductase Inhibitor Dutasteride Caused Reductions in Vascular Density and Area in Benign Prostatic Hyperplasia
by: Zaitsu, Masayoshi, et al.
Published: (2013)

5-α reductase inhibitors, benign prostatic hyperplasia, and risk of male breast cancer
by: Robinson, David, et al.
Published: (2015)

Combined effect of polymorphisms in type III 5-α reductase and androgen receptor gene with the risk of benign prostatic hyperplasia in Korea
by: Lee, Chung Lyul, et al.
Published: (2016)

Korean clinical practice guideline for benign prostatic hyperplasia
by: Yeo, Jeong Kyun, et al.
Published: (2016)

Benign Prostatic Hyperplasia
Published: (2015)

Testosterone and benign prostatic hyperplasia
by: Jarvis, Thomas R, et al.
Published: (2015)

Efficacy of Alpha Blocker Treatment According to the Degree of Intravesical Prostatic Protrusion Detected by Transrectal Ultrasonography in Patients with Benign Prostatic Hyperplasia
by: Park, Hee Young, et al.
Published: (2012)

Silodosin for the treatment of clinical benign prostatic hyperplasia: safety, efficacy, and patient acceptability
by: Cho, Hee Ju, et al.
Published: (2014)

Initial Experience With Transurethral Enucleation With Bipolar Energy for Benign Prostatic Hyperplasia
by: Dae Young Kim, et al.
Published: (2017-12-01)

Tuberculosis of the prostate presenting as benign prostatic hyperplasia.
by: Fazarina M,, et al.
Published: (2013)

Zinc status in benign prostatic hyperplasia and prostate carcinoma
by: Wiwanitkit, Somsri, et al.
Published: (2012)

Tuberculosis of the prostate presenting as benign prostatic hyperplasia
by: Perpustakaan Tun Seri Lanang
Published: (2013)

Technical Aspects of Holmium Laser Enucleation of the Prostate for Benign Prostatic Hyperplasia
by: Kim, Myong, et al.
Published: (2013)

Management of benign prostatic hyperplasia with silodosin
by: Yamanishi, Tomonori, et al.
Published: (2009)

Epidemiology of clinical benign prostatic hyperplasia
by: Kok Bin Lim
Published: (2017-07-01)

Pathophysiology of clinical benign prostatic hyperplasia
by: Keong Tatt Foo
Published: (2017-07-01)

Elevated expression of HIF-lα in actively growing prostate tissues is associated with clinical features of benign prostatic hyperplasia
by: Wu, Fei, et al.
Published: (2016)

Effect of Obesity on Prostate-Specific Antigen, Prostate Volume, and International Prostate Symptom Score in Patients with Benign Prostatic Hyperplasia
by: Kim, Jong Min, et al.
Published: (2011)

Effect of 5-alpha Reductase Inhibitor on Storage Symptoms in Patients with Benign Prostatic Hyperplasia
by: Cho, Kang Jun, et al.
Published: (2011)

Synergistic interaction of benign prostatic hyperplasia and prostatitis on prostate cancer risk
by: Hung, S-C, et al.
Published: (2013)

Expression and Localization of Aquaporins in Benign Prostate Hyperplasia and Prostate Cancer
by: Hwang, Insang, et al.
Published: (2012)

The Study About Physical Activity for Subjects With Prevention of Benign Prostate Hyperplasia
by: Lee, Ho Won, et al.
Published: (2014)

Inhibitory effects of Ponciri Fructus on testosterone-induced benign prostatic hyperplasia in rats
by: Woo-Young Jeon, et al.
Published: (2017-08-01)

Nationwide incidence and treatment pattern of benign prostatic hyperplasia in Korea
by: Lee, Young Ju, et al.
Published: (2016)

Linking Pre-Diabetes with Benign Prostate Hyperplasia. IGFBP-3: A Conductor of Benign Prostate Hyperplasia Development Orchestra?
by: Protopsaltis, Ioannis, et al.
Published: (2013)

Efficacy and Safety of the Selective α1A-Adrenoceptor Blocker Silodosin for Severe Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia: A Prospective, Single-Open-Label, Multicenter Study in Korea
by: Moon, Ki Hak, et al.
Published: (2014)

Initial Experiences with a 980 nm Diode Laser for Photoselective Vaporization of the Prostate for the Treatment of Benign Prostatic Hyperplasia
by: Yang, Ki Su, et al.
Published: (2011)

Clinical Effects of Discontinuing 5-Alpha Reductase Inhibitor in Patients With Benign Prostatic Hyperplasia
by: Kim, Won, et al.
Published: (2014)

Impact of preoperative 5α-reductase inhibitors on perioperative blood loss in patients with benign prostatic hyperplasia: a meta-analysis of randomized controlled trials
by: Zhu, Yi-Ping, et al.
Published: (2015)

Efficacy and safety of holmium laser enucleation of the prostate for extremely large prostatic adenoma in patients with benign prostatic hyperplasia
by: Kim, Myong, et al.
Published: (2015)

Prescription pattern of alpha-blockers for management of lower urinary tract symptoms/benign prostatic hyperplasia
by: Hyong Woo Moon, et al.
Published: (2018-09-01)

AB016. Which laser works best for benign prostatic hyperplasia?
by: Kim, Sae Woong
Published: (2015)

Relationship between Intravesical Prostatic Protrusion and Postoperative Outcomes in Patients with Benign Prostatic Hyperplasia
by: Lee, Jong Woo, et al.
Published: (2012)

Long-Term Effect of Loxoprofen Sodium on Nocturia in Patients with Benign Prostatic Hyperplasia
by: Shin, Hong Il, et al.
Published: (2011)